JP2023545183A5 - - Google Patents
Info
- Publication number
- JP2023545183A5 JP2023545183A5 JP2023522849A JP2023522849A JP2023545183A5 JP 2023545183 A5 JP2023545183 A5 JP 2023545183A5 JP 2023522849 A JP2023522849 A JP 2023522849A JP 2023522849 A JP2023522849 A JP 2023522849A JP 2023545183 A5 JP2023545183 A5 JP 2023545183A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- canine
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063092294P | 2020-10-15 | 2020-10-15 | |
| US202063092296P | 2020-10-15 | 2020-10-15 | |
| US63/092,296 | 2020-10-15 | ||
| US63/092,294 | 2020-10-15 | ||
| US202063127184P | 2020-12-18 | 2020-12-18 | |
| US63/127,184 | 2020-12-18 | ||
| US202163235257P | 2021-08-20 | 2021-08-20 | |
| US202163235258P | 2021-08-20 | 2021-08-20 | |
| US63/235,257 | 2021-08-20 | ||
| US63/235,258 | 2021-08-20 | ||
| PCT/EP2021/078386 WO2022079139A1 (en) | 2020-10-15 | 2021-10-14 | Caninized antibodies to canine interleukin-31 receptor alpha |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023545183A JP2023545183A (ja) | 2023-10-26 |
| JP2023545183A5 true JP2023545183A5 (enExample) | 2024-10-17 |
Family
ID=78302732
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023522848A Pending JP2023545182A (ja) | 2020-10-15 | 2021-10-14 | イヌインターロイキン－３１受容体アルファに対するイヌ化ラット抗体 |
| JP2023522849A Pending JP2023545183A (ja) | 2020-10-15 | 2021-10-14 | イヌインターロイキン－３１受容体アルファに対するイヌ化抗体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023522848A Pending JP2023545182A (ja) | 2020-10-15 | 2021-10-14 | イヌインターロイキン－３１受容体アルファに対するイヌ化ラット抗体 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20240002518A1 (enExample) |
| EP (2) | EP4229083A1 (enExample) |
| JP (2) | JP2023545182A (enExample) |
| CN (1) | CN116348488A (enExample) |
| AU (2) | AU2021359068A1 (enExample) |
| CA (2) | CA3194457A1 (enExample) |
| MX (2) | MX2023004438A (enExample) |
| WO (2) | WO2022079138A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3248329A1 (en) * | 2019-07-31 | 2025-11-29 | F. Hoffmann-La Roche Ag | Antibodies binding to gprc5d |
| JP2023545182A (ja) * | 2020-10-15 | 2023-10-26 | インターベット インターナショナル ベー． フェー． | イヌインターロイキン－３１受容体アルファに対するイヌ化ラット抗体 |
| US20240209096A1 (en) | 2022-12-27 | 2024-06-27 | Invetx, Inc. | Polypeptides with altered binding to neonatal fc receptor (fcrn) and methods of use |
| AU2024210302A1 (en) | 2023-01-20 | 2025-09-04 | Invetx, Inc. | Bispecific binding agents for use in companion animals |
| CN120865401A (zh) * | 2023-11-27 | 2025-10-31 | 宁波贝安生物科技有限公司 | 抗il-31的抗体及其用途 |
| WO2026032397A1 (en) * | 2024-08-09 | 2026-02-12 | Zai Lab (Shanghai) Co., Ltd. | Binding molecules with an interleukin-31 receptor subunit alpha-antigen-binding domain and uses thereof |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| EP0216846B2 (en) | 1985-04-01 | 1995-04-26 | Celltech Limited | Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| GB9818110D0 (en) | 1998-08-19 | 1998-10-14 | Weston Medical Ltd | Needleless injectors and other devices |
| US6096002A (en) | 1998-11-18 | 2000-08-01 | Bioject, Inc. | NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method |
| US7696222B2 (en) | 2005-08-12 | 2010-04-13 | Merck Frosst Canada Ltd | Indole derivatives as CRTH2 receptor antagonists |
| KR101335843B1 (ko) | 2008-08-20 | 2013-12-02 | 조에티스 엘엘씨 | 피롤로[2,3-ｄ]피리미딘 화합물 |
| CA2736571A1 (en) | 2008-09-22 | 2010-03-25 | Merck Frosst Canada Ltd. | Azaindole derivatives as crth2 receptor antagonists |
| WO2010031182A1 (en) | 2008-09-22 | 2010-03-25 | Merck Frosst Canada Ltd. | Indole derivatives as crth2 receptor antagonists |
| KR101445012B1 (ko) | 2009-12-17 | 2014-09-26 | 머크 샤프 앤드 돔 코포레이션 | Ｓｙｋ 억제제로서의 아미노피리미딘 |
| US8790651B2 (en) | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| TWI682781B (zh) | 2013-07-11 | 2020-01-21 | 美商再生元醫藥公司 | 藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法 |
| CN106029697B (zh) | 2013-12-20 | 2021-06-04 | 英特维特国际股份有限公司 | 具有经修饰的ch2-ch3序列的犬抗体 |
| CA2980087A1 (en) | 2015-04-02 | 2016-10-06 | Intervet International B.V. | Antibodies to canine interleukin-4 receptor alpha |
| US11091556B2 (en) * | 2015-12-18 | 2021-08-17 | Intervet Inc. | Caninized human antibodies to human IL-4R alpha |
| JP7116063B2 (ja) | 2016-12-14 | 2022-08-09 | インターベット インターナショナル ベー． フェー． | 選択的ヤヌスキナーゼ阻害剤としてのアミノピラゾール類 |
| US10093731B2 (en) | 2017-02-24 | 2018-10-09 | Kindred Biosciences, Inc. | Anti-IL31 antibodies for veterinary use |
| US11236157B2 (en) * | 2019-01-28 | 2022-02-01 | Galderma Holding SA | Treatment of skin lesions and pruritus in prurigo nodularis patients |
| CN110563844A (zh) | 2019-09-04 | 2019-12-13 | 华中农业大学 | 一种抗犬白介素31受体的多克隆抗体及其应用 |
| JP2023545182A (ja) * | 2020-10-15 | 2023-10-26 | インターベット インターナショナル ベー． フェー． | イヌインターロイキン－３１受容体アルファに対するイヌ化ラット抗体 |
-
2021
- 2021-10-14 JP JP2023522848A patent/JP2023545182A/ja active Pending
- 2021-10-14 EP EP21794768.8A patent/EP4229083A1/en active Pending
- 2021-10-14 MX MX2023004438A patent/MX2023004438A/es unknown
- 2021-10-14 US US18/247,661 patent/US20240002518A1/en active Pending
- 2021-10-14 WO PCT/EP2021/078385 patent/WO2022079138A1/en not_active Ceased
- 2021-10-14 CA CA3194457A patent/CA3194457A1/en active Pending
- 2021-10-14 AU AU2021359068A patent/AU2021359068A1/en active Pending
- 2021-10-14 US US18/247,653 patent/US12577310B2/en active Active
- 2021-10-14 MX MX2023004439A patent/MX2023004439A/es unknown
- 2021-10-14 AU AU2021360208A patent/AU2021360208A1/en active Pending
- 2021-10-14 CN CN202180070828.2A patent/CN116348488A/zh active Pending
- 2021-10-14 WO PCT/EP2021/078386 patent/WO2022079139A1/en not_active Ceased
- 2021-10-14 EP EP21798582.9A patent/EP4229084A1/en active Pending
- 2021-10-14 JP JP2023522849A patent/JP2023545183A/ja active Pending
- 2021-10-14 CA CA3194384A patent/CA3194384A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023545183A5 (enExample) | ||
| JP2023545182A5 (enExample) | ||
| JP2022177090A5 (enExample) | ||
| JP2021521843A5 (enExample) | ||
| RU2017134495A (ru) | Антитела к альфа-рецептору собачьего интерлейкина-4 | |
| JP2022191383A5 (enExample) | ||
| JP2024038003A5 (enExample) | ||
| JP2024522360A5 (enExample) | ||
| JP2021529557A5 (enExample) | ||
| JP2022523442A5 (enExample) | ||
| JP2012010714A5 (enExample) | ||
| JP2022533538A5 (enExample) | ||
| JP2021501744A5 (enExample) | ||
| JP2023093753A5 (enExample) | ||
| JP2012525829A5 (enExample) | ||
| HRP20120701T1 (hr) | Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1 | |
| RU2020130795A (ru) | Нейтрализующие антитела к env вич-1 и их применение | |
| JP2025183307A5 (enExample) | ||
| JP2011527899A5 (enExample) | ||
| JP2025067915A5 (enExample) | ||
| CN110869390A (zh) | 抗pd-l1抗体及其用途 | |
| RU2012103212A (ru) | Tlr3 связывающие агенты | |
| JP2023510844A5 (enExample) | ||
| JP2020522280A5 (enExample) | ||
| JP2024540148A5 (enExample) |